OrbiMed Israel BioFund GP Limited Partnership's Net Worth

Estimate Recalculated Apr 21, 2025 12:25PM EST

Who is OrbiMed Israel BioFund GP Limited Partnership

OrbiMed Israel BioFund GP Limited Partnership does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., BiomX Inc., Chemomab Therapeutics Ltd., INNOVATE BIOPHARMACEUTICALS, INC., and Novus Therapeutics, Inc..

SEC CIK

OrbiMed Israel BioFund GP Limited Partnership's CIK is 0001569821

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BiomX Inc.

Investor

Updated May 20, 2024

View Quote Details


Form 4	-0.18%	-24.34K	$0.31	$2.26M	May 20, 2024	13.77M	Sale	—	May 15
Form 4	—	2.17M	—	—	Mar 19, 2024	2.17M	Purchase	—	Mar 15
Form 4	75.99%	2.14M	$0.25	$85.26K	Mar 17, 2023	4.95M	Purchase	—	Feb 27
Form 4	37.82%	875.00K	—	—	Jul 30, 2021	3.19M	Purchase	—	Jul 28
Form 4	0.17%	4.00K	$8.90	$35.62K	Dec 20, 2019	2.31M	Purchase	—	Dec 18 - Dec 19
Form 4	0.38%	8.80K	$8.85	$77.92K	Dec 12, 2019	2.31M	Purchase	—	Dec 10 - Dec 11
Form 4	0.45%	10.20K	$8.40	$85.65K	Dec 09, 2019	2.30M	Purchase	—	Dec 05 - Dec 09
Form 3	—	—	—	—	Nov 07, 2019	2.29M	—	—	—

Showing 8 results

Adicet Bio, Inc.

Investor

Updated Jan 26, 2024

View Quote Details


Form 4	47.01%	3.13M	$2.40	$7.50M	Jan 26, 2024	11.45M	Purchase	—	Jan 25
Form 4	12.10%	875.00K	$2.09	$1.83M	Jun 29, 2023	8.32M	Purchase	—	Jun 27
Form 4	765.30%	214.28K	$14.00	$3.00M	Dec 14, 2021	7.48M	Grant	—	Dec 10
Form 4	10.25%	524.35K	$13.00	$6.82M	Feb 18, 2021	7.23M	Grant	—	Feb 12
Form 4	—	6.08M	—	—	Sep 17, 2020	6.77M	Grant	—	Sep 15 - Sep 17
Form 3	—	—	—	—	Sep 17, 2020	—	—	—	—

Showing 6 results

Chemomab Therapeutics Ltd.

Investor

Updated Jan 05, 2023

View Quote Details


Form 4	-13.07%	-336.90K	$3.58	-$1.21M	Jan 05, 2023	2.24M	Sale	—	Jan 03
Form 3	—	—	—	—	Mar 26, 2021	2.29M	—	—	—
Form 4	13.84%	316.99K	$17.35	$5.00M	Mar 18, 2021	2.61M	Grant	—	Mar 16

Showing 3 results

9 METERS BIOPHARMA, INC.

Investor

Updated Jun 25, 2021

View Quote Details


Form 4	-66.69%	-17.15M	$1.22	-$20.93M	Jun 25, 2021	8.60M	Sale	—	Jun 23 - Jun 25
Form 4	0.12%	63.89K	$0.66	$20.84K	May 13, 2021	51.60M	Options	—	May 11
Form 4/A	141.89%	19.07M	—	—	Mar 19, 2021	32.50M	Purchase	—	Apr 30 - May 04
Form 4	8.18%	1.94M	—	—	Nov 03, 2020	25.72M	Acquisition	—	Oct 30
Form 4	39.40%	6.72M	—	—	Jul 02, 2020	23.77M	Options	—	Jun 30
Form 4	1.01%	135.73K	—	—	May 05, 2020	13.57M	Purchase	—	May 04
Form 4	—	50.00K	—	—	May 04, 2020	50.00K	Grant	—	Apr 30
Form 3	—	—	—	—	May 04, 2020	16.99M	—	—	—

Showing 8 results

Novus Therapeutics, Inc.

Investor

Updated Dec 04, 2020

View Quote Details


Form 4	-58.35%	-103.20K	$21.60	-$2.23M	Dec 04, 2020	73.65K	Sale	—	Dec 02
Form 4	—	1.29M	$0.20	$258.48K	Feb 25, 2020	—	s	—	Jan 14
Form 4	76.41%	1.94M	$3.10	$2.00M	May 06, 2019	4.48M	Purchase	—	May 02
Form 4	—	2.54M	—	—	May 11, 2017	2.54M	Grant	—	May 09
Form 3	—	—	—	—	May 11, 2017	—	—	—	—

Showing 5 results